0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cystic Fibrosis Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-10Z7196
Home | Market Reports | Health| Pharmacy
Global Cystic Fibrosis Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cystic Fibrosis Drugs Market Research Report 2025

Code: QYRE-Auto-10Z7196
Report
August 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cystic Fibrosis Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cystic Fibrosis Drugs Market

Cystic Fibrosis Drugs Market

The global market for Cystic Fibrosis Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis Drugs.
The Cystic Fibrosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cystic Fibrosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cystic Fibrosis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cystic Fibrosis Drugs Market Report

Report Metric Details
Report Name Cystic Fibrosis Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Actavis, F. Hoffmann-La Roche, Gilead Sciences, Novartis, Vertex Pharmaceuticals, Abbott, Anthera Pharmaceuticals, Arcturus Therapeutics, Boehringer Ingelheim, Chiesi Farmaceutici, Corbus Pharmaceuticals, Genzyme, Insmed, Johnson & Johnson, Merck Sharp & Dohme, Neovii Biotech, Novo Nordisk, PharmaSwiss, Pharmaxis, Proteostasis Therapeutics, PTC Therapeutics, United Medical, Venus Remedies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cystic Fibrosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cystic Fibrosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Cystic Fibrosis Drugs Market report?

Ans: The main players in the Cystic Fibrosis Drugs Market are Actavis, F. Hoffmann-La Roche, Gilead Sciences, Novartis, Vertex Pharmaceuticals, Abbott, Anthera Pharmaceuticals, Arcturus Therapeutics, Boehringer Ingelheim, Chiesi Farmaceutici, Corbus Pharmaceuticals, Genzyme, Insmed, Johnson & Johnson, Merck Sharp & Dohme, Neovii Biotech, Novo Nordisk, PharmaSwiss, Pharmaxis, Proteostasis Therapeutics, PTC Therapeutics, United Medical, Venus Remedies

What are the Application segmentation covered in the Cystic Fibrosis Drugs Market report?

Ans: The Applications covered in the Cystic Fibrosis Drugs Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Cystic Fibrosis Drugs Market report?

Ans: The Types covered in the Cystic Fibrosis Drugs Market report are Oral Cystic Fibrosis Drugs, Injection Cystic Fibrosis Drugs

Recommended Reports

Respiratory Diseases

Drug Market Analysis

Therapeutics & Diagnostics

1 Cystic Fibrosis Drugs Market Overview
1.1 Product Definition
1.2 Cystic Fibrosis Drugs by Type
1.2.1 Global Cystic Fibrosis Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Cystic Fibrosis Drugs
1.2.3 Injection Cystic Fibrosis Drugs
1.3 Cystic Fibrosis Drugs by Application
1.3.1 Global Cystic Fibrosis Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Cystic Fibrosis Drugs Market Size Estimates and Forecasts
1.4.1 Global Cystic Fibrosis Drugs Revenue 2020-2031
1.4.2 Global Cystic Fibrosis Drugs Sales 2020-2031
1.4.3 Global Cystic Fibrosis Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cystic Fibrosis Drugs Market Competition by Manufacturers
2.1 Global Cystic Fibrosis Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cystic Fibrosis Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cystic Fibrosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cystic Fibrosis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cystic Fibrosis Drugs, Product Type & Application
2.7 Global Key Manufacturers of Cystic Fibrosis Drugs, Date of Enter into This Industry
2.8 Global Cystic Fibrosis Drugs Market Competitive Situation and Trends
2.8.1 Global Cystic Fibrosis Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cystic Fibrosis Drugs Players Market Share by Revenue
2.8.3 Global Cystic Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cystic Fibrosis Drugs Market Scenario by Region
3.1 Global Cystic Fibrosis Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cystic Fibrosis Drugs Sales by Region: 2020-2031
3.2.1 Global Cystic Fibrosis Drugs Sales by Region: 2020-2025
3.2.2 Global Cystic Fibrosis Drugs Sales by Region: 2026-2031
3.3 Global Cystic Fibrosis Drugs Revenue by Region: 2020-2031
3.3.1 Global Cystic Fibrosis Drugs Revenue by Region: 2020-2025
3.3.2 Global Cystic Fibrosis Drugs Revenue by Region: 2026-2031
3.4 North America Cystic Fibrosis Drugs Market Facts & Figures by Country
3.4.1 North America Cystic Fibrosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cystic Fibrosis Drugs Sales by Country (2020-2031)
3.4.3 North America Cystic Fibrosis Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cystic Fibrosis Drugs Market Facts & Figures by Country
3.5.1 Europe Cystic Fibrosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cystic Fibrosis Drugs Sales by Country (2020-2031)
3.5.3 Europe Cystic Fibrosis Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cystic Fibrosis Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Cystic Fibrosis Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cystic Fibrosis Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Cystic Fibrosis Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cystic Fibrosis Drugs Market Facts & Figures by Country
3.7.1 Latin America Cystic Fibrosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cystic Fibrosis Drugs Sales by Country (2020-2031)
3.7.3 Latin America Cystic Fibrosis Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cystic Fibrosis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Cystic Fibrosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cystic Fibrosis Drugs Sales by Type (2020-2031)
4.1.1 Global Cystic Fibrosis Drugs Sales by Type (2020-2025)
4.1.2 Global Cystic Fibrosis Drugs Sales by Type (2026-2031)
4.1.3 Global Cystic Fibrosis Drugs Sales Market Share by Type (2020-2031)
4.2 Global Cystic Fibrosis Drugs Revenue by Type (2020-2031)
4.2.1 Global Cystic Fibrosis Drugs Revenue by Type (2020-2025)
4.2.2 Global Cystic Fibrosis Drugs Revenue by Type (2026-2031)
4.2.3 Global Cystic Fibrosis Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Cystic Fibrosis Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cystic Fibrosis Drugs Sales by Application (2020-2031)
5.1.1 Global Cystic Fibrosis Drugs Sales by Application (2020-2025)
5.1.2 Global Cystic Fibrosis Drugs Sales by Application (2026-2031)
5.1.3 Global Cystic Fibrosis Drugs Sales Market Share by Application (2020-2031)
5.2 Global Cystic Fibrosis Drugs Revenue by Application (2020-2031)
5.2.1 Global Cystic Fibrosis Drugs Revenue by Application (2020-2025)
5.2.2 Global Cystic Fibrosis Drugs Revenue by Application (2026-2031)
5.2.3 Global Cystic Fibrosis Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Cystic Fibrosis Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Actavis
6.1.1 Actavis Company Information
6.1.2 Actavis Description and Business Overview
6.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Actavis Cystic Fibrosis Drugs Product Portfolio
6.1.5 Actavis Recent Developments/Updates
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Company Information
6.2.2 F. Hoffmann-La Roche Description and Business Overview
6.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
6.2.5 F. Hoffmann-La Roche Recent Developments/Updates
6.3 Gilead Sciences
6.3.1 Gilead Sciences Company Information
6.3.2 Gilead Sciences Description and Business Overview
6.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
6.3.5 Gilead Sciences Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Cystic Fibrosis Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Vertex Pharmaceuticals
6.5.1 Vertex Pharmaceuticals Company Information
6.5.2 Vertex Pharmaceuticals Description and Business Overview
6.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.5.5 Vertex Pharmaceuticals Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Company Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Abbott Cystic Fibrosis Drugs Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Anthera Pharmaceuticals
6.7.1 Anthera Pharmaceuticals Company Information
6.7.2 Anthera Pharmaceuticals Description and Business Overview
6.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.7.5 Anthera Pharmaceuticals Recent Developments/Updates
6.8 Arcturus Therapeutics
6.8.1 Arcturus Therapeutics Company Information
6.8.2 Arcturus Therapeutics Description and Business Overview
6.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.8.5 Arcturus Therapeutics Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Company Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Chiesi Farmaceutici
6.10.1 Chiesi Farmaceutici Company Information
6.10.2 Chiesi Farmaceutici Description and Business Overview
6.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
6.10.5 Chiesi Farmaceutici Recent Developments/Updates
6.11 Corbus Pharmaceuticals
6.11.1 Corbus Pharmaceuticals Company Information
6.11.2 Corbus Pharmaceuticals Description and Business Overview
6.11.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.11.5 Corbus Pharmaceuticals Recent Developments/Updates
6.12 Genzyme
6.12.1 Genzyme Company Information
6.12.2 Genzyme Description and Business Overview
6.12.3 Genzyme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Genzyme Cystic Fibrosis Drugs Product Portfolio
6.12.5 Genzyme Recent Developments/Updates
6.13 Insmed
6.13.1 Insmed Company Information
6.13.2 Insmed Description and Business Overview
6.13.3 Insmed Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Insmed Cystic Fibrosis Drugs Product Portfolio
6.13.5 Insmed Recent Developments/Updates
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Company Information
6.14.2 Johnson & Johnson Description and Business Overview
6.14.3 Johnson & Johnson Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
6.14.5 Johnson & Johnson Recent Developments/Updates
6.15 Merck Sharp & Dohme
6.15.1 Merck Sharp & Dohme Company Information
6.15.2 Merck Sharp & Dohme Description and Business Overview
6.15.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
6.15.5 Merck Sharp & Dohme Recent Developments/Updates
6.16 Neovii Biotech
6.16.1 Neovii Biotech Company Information
6.16.2 Neovii Biotech Description and Business Overview
6.16.3 Neovii Biotech Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
6.16.5 Neovii Biotech Recent Developments/Updates
6.17 Novo Nordisk
6.17.1 Novo Nordisk Company Information
6.17.2 Novo Nordisk Description and Business Overview
6.17.3 Novo Nordisk Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
6.17.5 Novo Nordisk Recent Developments/Updates
6.18 PharmaSwiss
6.18.1 PharmaSwiss Company Information
6.18.2 PharmaSwiss Description and Business Overview
6.18.3 PharmaSwiss Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
6.18.5 PharmaSwiss Recent Developments/Updates
6.19 Pharmaxis
6.19.1 Pharmaxis Company Information
6.19.2 Pharmaxis Description and Business Overview
6.19.3 Pharmaxis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Pharmaxis Cystic Fibrosis Drugs Product Portfolio
6.19.5 Pharmaxis Recent Developments/Updates
6.20 Proteostasis Therapeutics
6.20.1 Proteostasis Therapeutics Company Information
6.20.2 Proteostasis Therapeutics Description and Business Overview
6.20.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.20.5 Proteostasis Therapeutics Recent Developments/Updates
6.21 PTC Therapeutics
6.21.1 PTC Therapeutics Company Information
6.21.2 PTC Therapeutics Description and Business Overview
6.21.3 PTC Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.21.5 PTC Therapeutics Recent Developments/Updates
6.22 United Medical
6.22.1 United Medical Company Information
6.22.2 United Medical Description and Business Overview
6.22.3 United Medical Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 United Medical Cystic Fibrosis Drugs Product Portfolio
6.22.5 United Medical Recent Developments/Updates
6.23 Venus Remedies
6.23.1 Venus Remedies Company Information
6.23.2 Venus Remedies Description and Business Overview
6.23.3 Venus Remedies Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Venus Remedies Cystic Fibrosis Drugs Product Portfolio
6.23.5 Venus Remedies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cystic Fibrosis Drugs Industry Chain Analysis
7.2 Cystic Fibrosis Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cystic Fibrosis Drugs Production Mode & Process Analysis
7.4 Cystic Fibrosis Drugs Sales and Marketing
7.4.1 Cystic Fibrosis Drugs Sales Channels
7.4.2 Cystic Fibrosis Drugs Distributors
7.5 Cystic Fibrosis Drugs Customer Analysis
8 Cystic Fibrosis Drugs Market Dynamics
8.1 Cystic Fibrosis Drugs Industry Trends
8.2 Cystic Fibrosis Drugs Market Drivers
8.3 Cystic Fibrosis Drugs Market Challenges
8.4 Cystic Fibrosis Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Cystic Fibrosis Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cystic Fibrosis Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cystic Fibrosis Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cystic Fibrosis Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Cystic Fibrosis Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cystic Fibrosis Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cystic Fibrosis Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cystic Fibrosis Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cystic Fibrosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cystic Fibrosis Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cystic Fibrosis Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Cystic Fibrosis Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cystic Fibrosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cystic Fibrosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cystic Fibrosis Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Cystic Fibrosis Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Cystic Fibrosis Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Cystic Fibrosis Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Cystic Fibrosis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Cystic Fibrosis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cystic Fibrosis Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Cystic Fibrosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cystic Fibrosis Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Cystic Fibrosis Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Cystic Fibrosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cystic Fibrosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cystic Fibrosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cystic Fibrosis Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Cystic Fibrosis Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Cystic Fibrosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cystic Fibrosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cystic Fibrosis Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cystic Fibrosis Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Cystic Fibrosis Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Cystic Fibrosis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cystic Fibrosis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cystic Fibrosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cystic Fibrosis Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Cystic Fibrosis Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Cystic Fibrosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cystic Fibrosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cystic Fibrosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cystic Fibrosis Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Cystic Fibrosis Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Cystic Fibrosis Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Cystic Fibrosis Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Cystic Fibrosis Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cystic Fibrosis Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Cystic Fibrosis Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Cystic Fibrosis Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Cystic Fibrosis Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Cystic Fibrosis Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Cystic Fibrosis Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Cystic Fibrosis Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Cystic Fibrosis Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cystic Fibrosis Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cystic Fibrosis Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Cystic Fibrosis Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Cystic Fibrosis Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Cystic Fibrosis Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. Actavis Company Information
 Table 71. Actavis Description and Business Overview
 Table 72. Actavis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Actavis Cystic Fibrosis Drugs Product
 Table 74. Actavis Recent Developments/Updates
 Table 75. F. Hoffmann-La Roche Company Information
 Table 76. F. Hoffmann-La Roche Description and Business Overview
 Table 77. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product
 Table 79. F. Hoffmann-La Roche Recent Developments/Updates
 Table 80. Gilead Sciences Company Information
 Table 81. Gilead Sciences Description and Business Overview
 Table 82. Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Gilead Sciences Cystic Fibrosis Drugs Product
 Table 84. Gilead Sciences Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Novartis Cystic Fibrosis Drugs Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Vertex Pharmaceuticals Company Information
 Table 91. Vertex Pharmaceuticals Description and Business Overview
 Table 92. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product
 Table 94. Vertex Pharmaceuticals Recent Developments/Updates
 Table 95. Abbott Company Information
 Table 96. Abbott Description and Business Overview
 Table 97. Abbott Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Abbott Cystic Fibrosis Drugs Product
 Table 99. Abbott Recent Developments/Updates
 Table 100. Anthera Pharmaceuticals Company Information
 Table 101. Anthera Pharmaceuticals Description and Business Overview
 Table 102. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product
 Table 104. Anthera Pharmaceuticals Recent Developments/Updates
 Table 105. Arcturus Therapeutics Company Information
 Table 106. Arcturus Therapeutics Description and Business Overview
 Table 107. Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Arcturus Therapeutics Cystic Fibrosis Drugs Product
 Table 109. Arcturus Therapeutics Recent Developments/Updates
 Table 110. Boehringer Ingelheim Company Information
 Table 111. Boehringer Ingelheim Description and Business Overview
 Table 112. Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Boehringer Ingelheim Cystic Fibrosis Drugs Product
 Table 114. Boehringer Ingelheim Recent Developments/Updates
 Table 115. Chiesi Farmaceutici Company Information
 Table 116. Chiesi Farmaceutici Description and Business Overview
 Table 117. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Chiesi Farmaceutici Cystic Fibrosis Drugs Product
 Table 119. Chiesi Farmaceutici Recent Developments/Updates
 Table 120. Corbus Pharmaceuticals Company Information
 Table 121. Corbus Pharmaceuticals Description and Business Overview
 Table 122. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product
 Table 124. Corbus Pharmaceuticals Recent Developments/Updates
 Table 125. Genzyme Company Information
 Table 126. Genzyme Description and Business Overview
 Table 127. Genzyme Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Genzyme Cystic Fibrosis Drugs Product
 Table 129. Genzyme Recent Developments/Updates
 Table 130. Insmed Company Information
 Table 131. Insmed Description and Business Overview
 Table 132. Insmed Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Insmed Cystic Fibrosis Drugs Product
 Table 134. Insmed Recent Developments/Updates
 Table 135. Johnson & Johnson Company Information
 Table 136. Johnson & Johnson Description and Business Overview
 Table 137. Johnson & Johnson Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Johnson & Johnson Cystic Fibrosis Drugs Product
 Table 139. Johnson & Johnson Recent Developments/Updates
 Table 140. Merck Sharp & Dohme Company Information
 Table 141. Merck Sharp & Dohme Description and Business Overview
 Table 142. Merck Sharp & Dohme Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Merck Sharp & Dohme Cystic Fibrosis Drugs Product
 Table 144. Merck Sharp & Dohme Recent Developments/Updates
 Table 145. Neovii Biotech Company Information
 Table 146. Neovii Biotech Description and Business Overview
 Table 147. Neovii Biotech Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 148. Neovii Biotech Cystic Fibrosis Drugs Product
 Table 149. Neovii Biotech Recent Developments/Updates
 Table 150. Novo Nordisk Company Information
 Table 151. Novo Nordisk Description and Business Overview
 Table 152. Novo Nordisk Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 153. Novo Nordisk Cystic Fibrosis Drugs Product
 Table 154. Novo Nordisk Recent Developments/Updates
 Table 155. PharmaSwiss Company Information
 Table 156. PharmaSwiss Description and Business Overview
 Table 157. PharmaSwiss Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 158. PharmaSwiss Cystic Fibrosis Drugs Product
 Table 159. PharmaSwiss Recent Developments/Updates
 Table 160. Pharmaxis Company Information
 Table 161. Pharmaxis Description and Business Overview
 Table 162. Pharmaxis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 163. Pharmaxis Cystic Fibrosis Drugs Product
 Table 164. Pharmaxis Recent Developments/Updates
 Table 165. Proteostasis Therapeutics Company Information
 Table 166. Proteostasis Therapeutics Description and Business Overview
 Table 167. Proteostasis Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 168. Proteostasis Therapeutics Cystic Fibrosis Drugs Product
 Table 169. Proteostasis Therapeutics Recent Developments/Updates
 Table 170. PTC Therapeutics Company Information
 Table 171. PTC Therapeutics Description and Business Overview
 Table 172. PTC Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 173. PTC Therapeutics Cystic Fibrosis Drugs Product
 Table 174. PTC Therapeutics Recent Developments/Updates
 Table 175. United Medical Company Information
 Table 176. United Medical Description and Business Overview
 Table 177. United Medical Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 178. United Medical Cystic Fibrosis Drugs Product
 Table 179. United Medical Recent Developments/Updates
 Table 180. Venus Remedies Company Information
 Table 181. Venus Remedies Description and Business Overview
 Table 182. Venus Remedies Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 183. Venus Remedies Cystic Fibrosis Drugs Product
 Table 184. Venus Remedies Recent Developments/Updates
 Table 185. Key Raw Materials Lists
 Table 186. Raw Materials Key Suppliers Lists
 Table 187. Cystic Fibrosis Drugs Distributors List
 Table 188. Cystic Fibrosis Drugs Customers List
 Table 189. Cystic Fibrosis Drugs Market Trends
 Table 190. Cystic Fibrosis Drugs Market Drivers
 Table 191. Cystic Fibrosis Drugs Market Challenges
 Table 192. Cystic Fibrosis Drugs Market Restraints
 Table 193. Research Programs/Design for This Report
 Table 194. Key Data Information from Secondary Sources
 Table 195. Key Data Information from Primary Sources
 Table 196. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cystic Fibrosis Drugs
 Figure 2. Global Cystic Fibrosis Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cystic Fibrosis Drugs Market Share by Type: 2024 & 2031
 Figure 4. Oral Cystic Fibrosis Drugs Product Picture
 Figure 5. Injection Cystic Fibrosis Drugs Product Picture
 Figure 6. Global Cystic Fibrosis Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cystic Fibrosis Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Other
 Figure 11. Global Cystic Fibrosis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Cystic Fibrosis Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Cystic Fibrosis Drugs Sales (2020-2031) & (K Pcs)
 Figure 14. Global Cystic Fibrosis Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 15. Cystic Fibrosis Drugs Report Years Considered
 Figure 16. Cystic Fibrosis Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Cystic Fibrosis Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Cystic Fibrosis Drugs Players: Market Share by Revenue in Cystic Fibrosis Drugs in 2024
 Figure 19. Cystic Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Cystic Fibrosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Cystic Fibrosis Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Cystic Fibrosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Cystic Fibrosis Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Cystic Fibrosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Cystic Fibrosis Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Cystic Fibrosis Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Cystic Fibrosis Drugs Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Cystic Fibrosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Cystic Fibrosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Cystic Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Cystic Fibrosis Drugs by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Cystic Fibrosis Drugs by Type (2020-2031)
 Figure 55. Global Cystic Fibrosis Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Cystic Fibrosis Drugs by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Cystic Fibrosis Drugs by Application (2020-2031)
 Figure 58. Global Cystic Fibrosis Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 59. Cystic Fibrosis Drugs Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS